HSD63 Use of Resources and Cost in the Management of Gastrointestinal Bleeding Associated With Direct Oral Anticoagulants or Warfarin
Manuel Enrique Machado‐Duque(Technological University of Pereira), A. Mesa, J Machado-Alba(Technological University of Pereira), J Arciniegas, JM Reyes Sanchez, Andrés Gaviria‐Mendoza(Technological University of Pereira), N. Castaño Gamboa(Pfizer (United Kingdom)), Laura Restrepo(Technological University of Pereira)
Cited by 0
Related Papers
Use of healthcare resources in a cohort of rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs or tofacitinib
|Clinical Rheumatology|2020|9
PCN210 RESOURCE UTILIZATION AND COST FOR WOMEN WITH ADVANCED HR+/HER2- BREAST CANCER IN COLOMBIAN HEALTH CARE SETTINGS
|Value in Health|2019|6
Budget Impact Analysis of Anticoagulation Clinics in Patients with Atrial Fibrillation under Chronic Therapy with Oral Anticoagulants
|Journal of Primary Care & Community Health|2021|3